Status:
COMPLETED
National Survey on Dyslipidemic Patients
Lead Sponsor:
AstraZeneca
Conditions:
Dyslipidemia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this observational study is to describe the time to lipid-lowering drug implementation in the management of dyslipidemic patients, according to the cardiovascular risk level.
Eligibility Criteria
Inclusion
- Diagnosis of dyslipemia made less than 2 years
- Treated by a lipid-lowering drug
- Agree to take part in the survey
Exclusion
- Patient included in a clinical trial
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
3655 Patients enrolled
Trial Details
Trial ID
NCT00701402
Start Date
June 1 2008
End Date
January 1 2009
Last Update
August 6 2009
Active Locations (1198)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Abbaretz, France
2
Research Site
Abbeville, France
3
Research Site
Ablon-sur-Seine, France
4
Research Site
Abrest, France